CN104491406A - Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation - Google Patents
Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation Download PDFInfo
- Publication number
- CN104491406A CN104491406A CN201410757725.5A CN201410757725A CN104491406A CN 104491406 A CN104491406 A CN 104491406A CN 201410757725 A CN201410757725 A CN 201410757725A CN 104491406 A CN104491406 A CN 104491406A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine preparation
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 238000009835 boiling Methods 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000004204 blood vessel Anatomy 0.000 abstract description 7
- 210000004165 myocardium Anatomy 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 2
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 210000004351 coronary vessel Anatomy 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 239000001301 oxygen Substances 0.000 abstract description 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 235000014493 Crataegus Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 abstract 1
- 241000195955 Equisetum hyemale Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 241000037831 Polygonatum sibiricum Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010040007 Sense of oppression Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010049119 Emotional distress Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000009429 distress Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010049077 Hernia pain Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241001060310 Styracaceae Species 0.000 description 1
- 235000001361 Styrax officinalis Nutrition 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000009465 diaoxinxuekang Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008065 myocardial cell damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000031990 negative regulation of inflammatory response Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 206010030899 opisthotonus Diseases 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine preparation for treating coronary heart disease and a preparation method of the traditional Chinese medicine preparation. The traditional Chinese medicine preparation is characterized by being prepared from the following traditional Chinese medicine raw materials in parts by weight: 25-35 parts of panax pseudoginseng, 25-35 parts of salvia miltiorrhiza, 10-20 parts of radix rehmanniae praeparata, 10-20 parts of ligusticum wallichii, 5-8 parts of polygonatum sibiricum, 25-35 parts of tuckahoe, 5-8 parts of gynostemma pentaphyllum, 5-10 parts of green tangerine peel, 10-20 parts of coptis chinensis, 3-5 parts of polygala tenuifolia, 5-10 parts of eucommia ulmoides, 1-2 parts of hawthorns, 3-5 parts of semen plantaginis, 25-35 parts of cassia twigs, 10-20 parts of equisetum hyemale, 5-10 parts of rhizoma anemarrhenae and 3-5 parts of cinnamon. The traditional Chinese medicine preparation has the advantage that the adopted traditional Chinese medicines conform to the regulation of pharmacopoeia of people republic of China so as to be safe and reliable. All the traditional Chinese medicines are matched, so that the coronary blood flow can be improved, the cardiac muscle oxygen content can be increased, the demands of the cardiac muscles to blood are increased, and the effects of improving the activity of arterial blood vessel walls and enhancing the elasticity of the coronary artery are achieved; and the traditional Chinese medicine preparation has the characteristics of exact curative effect, high effect taking speed, high cure rate, no side effects and the like when being used for treating the coronary heart disease.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of Chinese medicine preparation for the treatment of coronary heart disease and preparation method thereof.
Background technology
Coronary heart disease (coronary heart disease) is a kind of commonly encountered diseases and frequently-occurring disease of serious harm human health, along with raising and the aged tendency of population of people's living standard, the sickness rate of primary disease and case fatality rate occupy first place in cardiovascular disease and ascendant trend is obvious year by year, becomes " first killer " of harm humans health.Point out in the report that World Health Organization (WHO) (WHO) is nearest, the mortality rate of 2000-2020 myocardial infarction will rise to the 1st by the 5th.The control of cardiovascular major disease is classified as priority research areas by " National Program for Medium-to Long-term Scientific and Technological Development (2006 ~ 2020) " and " scientific tcm research and development outline ".
The Etiological of coronary heart disease is atherosclerosis (atherosclerosis, AS), and the myocardial ischemia caused thus, downright bad pathological change.Its pathology pathogenesis is mainly because lipid metabolic disorder makes blood fat raise, blood vessel lipidosis, soak molten, blood vessel endothelium foam wanshing, the reaction of blood vessel wall chronic inflammatory makes the damage of coronary blood endothelial tube function and morphology, forms blood vessel endothelium atheromatous plaque, there is plaque rupture further, thrombosis, angiostenosis or obturation make coronary blood circulation obstacle, myocardial ischemia, myocardial cell damage, causes cardiac insufficiency.Coronary heart disease is mainly divided into clinically: (1) conceal type; (2) angina pectoris; (3) myocardial infarction; (4) heart failure type; (5) sudden death type.
The prevention of coronary heart disease or treatment are based on the change of dietary life habits and Lipid modulating, and coordinate the Drug therapys such as antiplatelet drug, nitrate esters and beta-blocker to alleviate the symptom of patient, improve the quality of living, improving prognosis is target.
Motherland's medical science thinks the category that coronary heart disease belongs to " obstruction of qi in the chest and cardialgia ", and the generation of primary disease is many by healthy energy virtual loss or expectorant is turbid, blood stasis, the stagnation of QI, cold coagulation and cause blockage of the cardiac vessels not smooth.Chinese medicine is with " blood circulation promoting and blood stasis dispelling " for basic rule for the treatment of treatment coronary heart disease for many years, achieves noticeable achievement.As FUFANG DANSHEN PIAN, Radix Salviae Miltiorrhizae drop pill, storax pill for treating coronary heart disease etc.In recent years clinically for the pathological change such as patients with coronary heart disease blood vessel, myocardial inflammation reaction, peroxidating stress damage, tissue necrosis; adopt the method for the treatment of such as " reducing phlegm ", " removing toxic substances ", " the turbid descending " respectively; research confirms that plurality of Chinese is by different approach and the link such as balance, anti-inflammatory response between regulating lipid metabolism, protection vascular endothelial cell, anti-lipid peroxidation, suppression vascular smooth muscle cell proliferation, adjustment Proliferation and apoptosis, intervenes and treatment coronary heart disease by experiment.As DIAOXINXUE KANG, Fructus Trichosanthis Rhizoma Pinelliae Bulbus Allii Macrostemonis soup, Rhizoma Coptidis toxic materials clearing away decoction, Rhizoma Curcumae Longae extract, puerarin extract, Monas cuspurpureus Went etc.
Chinese patent medicine is boundless comparatively speaking in the treatment market of coronary heart disease as can be seen here, urgently develops a kind of determined curative effect and the Chinese medicine of the treatment coronary heart disease remarkable, sophisticated technologies, drug quality are stable.
Summary of the invention
According to above the deficiencies in the prior art, the invention provides a kind of Chinese medicine preparation for the treatment of coronary heart disease and preparation method thereof, it is evident in efficacy, safe and reliable, have no side effect, there is wide potential applicability in clinical practice.
A kind of Chinese medicine preparation for the treatment of coronary heart disease of the present invention, according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 25 ~ 35 parts, Radix Salviae Miltiorrhizae 25 ~ 35 parts, Radix Rehmanniae Preparata 10 ~ 20 parts, Rhizoma Chuanxiong 10 ~ 20 parts, Rhizoma Polygonati 5 ~ 8 parts, 25 ~ 35 parts, Poria, Herb Gynostemmae Pentaphylli 5 ~ 8 parts, 5 ~ 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 10 ~ 20 parts, Radix Polygalae 3 ~ 5 parts, the Cortex Eucommiae 5 ~ 10 parts, Fructus Crataegi 1 ~ 2 part, Semen Plantaginis 3 ~ 5 parts, Ramulus Cinnamomi 25 ~ 35 parts, Herba Equiseti Hiemalis 10 ~ 20 parts, the Rhizoma Anemarrhenae 5 ~ 10 parts and Cortex Cinnamomi 3 ~ 5 parts.
Wherein, preferred version is as follows:
According to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 25 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Rehmanniae Preparata 10 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Polygonati 5 parts, 25 parts, Poria, Herb Gynostemmae Pentaphylli 5 parts, 5 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 10 parts, Radix Polygalae 3 parts, the Cortex Eucommiae 5 parts, Fructus Crataegi 1 part, Semen Plantaginis 3 parts, Ramulus Cinnamomi 25 parts, Herba Equiseti Hiemalis 10 parts, the Rhizoma Anemarrhenae 5 parts and Cortex Cinnamomi 3 parts.
Also can according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 35 parts, Radix Salviae Miltiorrhizae 35 parts, Radix Rehmanniae Preparata 20 parts, Rhizoma Chuanxiong 20 parts, Rhizoma Polygonati 8 parts, 35 parts, Poria, Herb Gynostemmae Pentaphylli 8 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 20 parts, Radix Polygalae 5 parts, the Cortex Eucommiae 10 parts, Fructus Crataegi 2 parts, Semen Plantaginis 5 parts, Ramulus Cinnamomi 35 parts, Herba Equiseti Hiemalis 20 parts, the Rhizoma Anemarrhenae 10 parts and Cortex Cinnamomi 5 parts.
The preparation method of the Chinese medicine preparation for the treatment of coronary heart disease of the present invention, prepare in accordance with the following methods: take raw material of Chinese medicine according to formula and join in container, add water and cover powder immersion 10 ~ 20 minutes, add water again and do not have powder 3 ~ 5 centimetres, decoct with high heat and use slow fire boiling again instead 20 ~ 30 minutes to boiling, get filtrate; And then add water and do not have powder 3 ~ 5 centimetres, decoct with high heat and uses slow fire boiling again instead 15 ~ 20 minutes to boiling, then remove slag and get filtrate, twice filtrate merges.
During use, each 200 ~ 300ml, sooner or later respectively once.
Pharmacology analysis:
Radix Notoginseng: sweet micro-hardship, temperature, nontoxic.Enter liver, stomach, double enter the heart, large intestine.Hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Control haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, retention of lochia, fall and flutter blood stasis, traumatic hemorrhage, carbuncle pain.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature.Root is used as medicine, and containing TANSHINONES, is robustness emmenagogue, has blood stasis dispelling, tissue regeneration promoting, invigorates blood circulation, the effectiveness such as regulating menstruation, is gynecological's key medicine, cures mainly metrorrhagia, menoxenia, blood stasis, stomachache, dysmenorrhoea, amenorrhea, mausoleum pain.Good result is had to treatment coronary heart disease.In addition also control the weak insomnia of nerve, arthralgia, anemia, mastitis, lymphadenitis, arthritis, furuncle pain is swollen, erysipelas, acute, chronic hepatitis, nephropyelitis, traumatic injury, advanced schistosomiasis hepatosplenomegaly, epilepsy.
Radix Rehmanniae Preparata: sweet in the mouth; Warm in nature.Return liver; Kidney channel.Enrich blood moist; Benefit essence fills out marrow; For blood deficiency and yellow complexion; Dizzy cardiopalmus; Menoxenia; Collapse more than; Hepatic and renal YIN deficiency; Hectic fever night sweat; Seminal emission sexual impotence; Infertility; Menoxenia; Metrostaxis; Soreness of the waist and knees; Hiccough and deaf; The head is dim-sighted; Early whitening of beard and hair; Quench one's thirst; Constipation; To suffer from a deficiency of the kidney dyspnea with rapid and short breath.Modern study, the Dihuang polysaccharide contained by Radix Rehmanniae Preparata has obvious immune antitumor activity, also have significant heart tonifying, diuresis, protect the liver, blood sugar lowering, anti-proliferate, exudation, antiinflammatory, antifungal, the effect such as anti-radiation.
Rhizoma Chuanxiong: warm in nature, returns liver, gallbladder, heart channel, is usually used in blood-activating and qi-promoting, wind-expelling pain-stopping, and the pungent temperature of Rhizoma Chuanxiong is fragrant dry, walks and does not keep, can go loose, and the up mountain peak that reaches is pushed up; Enter blood system again, descendingly reach the sea of blood.Blood circulation promoting and blood stasis dispelling effect is extensive, the suitable various disease of stagnation of blood stasis; Wind-expelling pain-stopping, effectiveness is excellent, can control the diseases such as wind syndrome of head headache, rheumatic arthralgia.It is gas medicine in blood that former times people calls Rhizoma Chuanxiong, the functions such as pungent loose, the resolving depression of its residence of dangerous speech, sensible, pain relieving.
Rhizoma Polygonati: sweet is flat.Return spleen, lung, kidney channel.Boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney tonifying.For weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, interior-heat is quenched one's thirst.
Poria: sweet, light is flat.GUIXIN, spleen, kidney channel.Be used as medicine and there is the function of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Modern medicine study: Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect.
Herb Gynostemmae Pentaphylli: bitter in the mouth; Micro-sweet; Cool in nature.Bitter in the mouth; Micro-sweet; Cool in nature.Replenishing QI to invigorate the spleen, preventing phlegm from forming and stopping coughing, heat-clearing and toxic substances removing.Cure mainly body void weak; Nephrasthenia emission; Leukopenia; Hyperlipemia; Viral hepatitis; Chronic gastroenteritis; Chronic tracheitis.
Pericarpium Citri Reticulatae Viride: soothing the liver dispelling the stagnated QI; Removing food stagnancyization is stagnant.The distending pain over the hypochondrium of main stagnation of QI due to depression of the liver; Distending pain of the breast; Nodule in the breast; Acute mastitis; Hernia pain; The epigastric distending pain of stagnation of QI due to dyspepsia; And qi depression to blood stasis lump in the abdomen extremely; Chronic malaria addiction block.
Rhizoma Coptidis: pathogenic fire purging, dampness, removing toxic substances, parasite killing.Row pyretic toxicity when controlling, typhoid fever, intenseness of heat is vexed, feeling of fullness vomiting, bacillary dysentery, and diarrhea of heat type is suffered from abdominal pain, and lung knot is pressed, and tells, is defeated in battle, hematochezia, quench one's thirst, infantile malnutrition, ascariasis, pertussis, laryngopharynx swelling and pain, acute catarrhal conjunctivitis, aphtha, skin sore, eczema, the burning hot wound of soup.
Radix Polygalae: bitter, pungent, warm.Return through GUIXIN, kidney, lung meridian.: nourish heart blood, relieving convulsion, mind calming, loose sputum.Treat five types of epilepsy opisthotonus, frightenedly to jerk, mouth is spat saliva, and brothers' war is shaken, and syncope, urine reducing, controls reddish and whitish turbid urine, stranguria marked by chyluria, and spermatorrhea be can't help.
The Cortex Eucommiae: sweet, temperature, nontoxic.Return liver, kidney channel.The Cortex Eucommiae has invigorating the liver and kidney, and control spinal column ache, foot and knee flaccidity, dribbling urination, uncontrolled urination is itched, hypertension, antiabortive effect.The Cortex Eucommiae has regulating action in various degree to immune system, hormonal system, central nervous system, blood circulation and urinary system, the excited Pituitary Adrenalcortical system of Cortex Eucommiae energy, adrenal cortex reinforcing function.
Fructus Crataegi: sour in the mouth, cold, nontoxic.Enter spleen, stomach, Liver Channel.Help digestion long-pending, dissipating blood stasis blood, expelling tenia.Control meat to amass, lump in the abdomen, phlegm retention, feeling of fullness, acid regurgitation, dysentery, hemorrhoidal hamorrhage, lumbago, hernia after-pains in puerperal, lochiorrhea, children's's breast food is stagnated.Promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis.For meat stagnation, stomach alkane distension, dysentery stomachache, blood stasis amenorrhea, postpartum stagnation, trusted subordinate's twinge, hernia pain, hyperlipidemia.
Semen Plantaginis: sweet in the mouth, cold.Enter kidney, urinary bladder channel.Diuretic, heat clearing away, improving eyesight, eliminates the phlegm.Control urinary obstruction, stranguria with turbid discharge, leukorrhagia, hematuria, heat-damp in summer dysentery, cough ant phlegm, arthralgia chiefly caused by damp pathogen, conjunctival congestion is hidden from view.
Ramulus Cinnamomi: nature and flavor are pungent, sweet, temperature, enter lung, the heart, urinary bladder channel, cure mainly the conventional drugs for dispelling internal cold of interior cold, there is effect of complement sun, promoting blood circulation, warming the spleen and stomach, normal with invigorating the liver and kidney medicine, fill blood medicine compatibility, treats insufficiency of kidney-YANG, decline of the fire from the gate of life, cold extremities faint pulse, treat coldness and pain in the epigastrium, arthralgia due to cold lumbago with other drugs for dispelling internal cold compatibility, there is the effect of significantly analgesia and anti-cancer and cancer-preventing.
Herba Equiseti Hiemalis: sweet, bitter, flat.Return lung, liver, gallbladder meridian.Wind-dispelling heat-dissipating, expelling pathogenic factors from muscles, nebula removing.Cure mainly the raw nebula of order, epiphora induced by wind, discharging fresh blood stool, dysentery, de-liver, malaria, laryngalgia, carbuncle.
The Rhizoma Anemarrhenae: bitter in the mouth, cold.Enter lung, stomach, kidney channel.Nourishing YIN to lower pathogenic fire, moisturizes laxation.Control dysphoria with smothery sensation to quench one's thirst, hectic fever due to YIN-deficiency consumptive fever, cough due to lung-heat, constipation due to dry stool, dysuria.
Cortex Cinnamomi: pungent, sweet, hot greatly.Pungent, sweet, hot greatly.Mend fire supporing yang, let the fire back to its origin, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow.For sexual impotence, cold womb, chills and pain of the waist and kness, suffers from a deficiency of the kidney and breathes heavily, dizziness due to yang deficiency, conjunctival congestion pharyngalgia, trusted subordinate's cold type of pain, and deficiency and coldness is vomited and diarrhoea, colic of cold type, renal mass, amenorrhea, dysmenorrhea.
The invention has the advantages that used Chinese medicine meets Pharmacopoeia of People's Republic of China regulation, safety of medicine is reliable.All medicine phases and can coronary flow be improved, strengthen myocardium oxygen content, make the increase in demand of cardiac muscle to blood, reach the activity of dredging coronary blood tube wall, make the effects such as coronary artery elasticity increase, treatment coronary heart disease has that determined curative effect, instant effect, cure rate are high, the feature such as have no side effect.
Outcome measure:
1, case selection:
As the medicine for the treatment of coronary heart disease, select patients with coronary heart disease 100 example to carry out clinical observation, wherein man 52 example, women 48 example, age 45-85 year, 55 years old mean age, course of disease 1-10, average 2.8 years.
2, medicine for treatment:
Treatment group patient takes medicine of the present invention, each 200 ~ 300ml, sooner or later respectively once within 7 days, is a course for the treatment of, takes 3-4 the course for the treatment of continuously according to the state of an illness, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
3, Outcome measure:
Effective: body constitution strengthens, and the cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves;
Effective: body constitution strengthens, and the cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent;
Invalid: all diseases are unchanged.
4, therapeutic outcome:
Effective 55 examples, effective 39 examples, invalid 6 examples, total effective rate is 94%.
Below enumerate a model case:
Wang, female, 52 years old, patient's private prosecution before being admitted to hospital 4+ begin there is sensation of oppression over the chest with shortness of breath and dizziness without obvious cause, time with cardiopalmus, fatigue time can aggravate, can alleviate through having a rest, my Out-patient Department of once repeatedly seeing a doctor is surveyed blood and is found hypertension, reaches as high as 210/110mmHg, look into electrocardiogram prompting " deficiency myocardial blood supply ", be diagnosed as " coronary heart disease, essential hypertension ", give blood pressure lowering, expand the Western medicine oral medications such as blood vessel, symptom all can be alleviated, but is easy to repeatedly.Within nearly 5 days, comparatively before increase the weight of without obvious cause sense symptom, chest dull pain, when in time, done only, companion's shortness of breath and palpitation, has a dizzy spell, especially obvious afterwards with activity, but fearless cold heating, headache vomiting, dyspnea, abdominal pain and distension, cough and expectoration, deafness and tinnitus, aphasia hemiplegia etc., do not give treatment outside institute, my Out-patient Department of today again seeing a doctor, outpatient service is intended " coronary heart disease, essential hypertension " and is hospitalized and be admitted to hospital.Under occasion: sensation of oppression and faint pain in the chest, time when doing only, shortness of breath and palpitation, tiredness with no desire to speak, lustreless complexion, has a dizzy spell, meet labor what for, two just adjust.Take Chinese medicine preparation of the present invention subsequently, after taking 3 courses for the treatment of, the cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves, and after continuing to take 1 course for the treatment of, times for spraying reduces by half and adheres to long-term taking, does not occur obvious disease so far.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1:
A kind of Chinese medicine preparation for the treatment of coronary heart disease, according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 25 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Rehmanniae Preparata 10 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Polygonati 5 parts, 25 parts, Poria, Herb Gynostemmae Pentaphylli 5 parts, 5 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 10 parts, Radix Polygalae 3 parts, the Cortex Eucommiae 5 parts, Fructus Crataegi 1 part, Semen Plantaginis 3 parts, Ramulus Cinnamomi 25 parts, Herba Equiseti Hiemalis 10 parts, the Rhizoma Anemarrhenae 5 parts and Cortex Cinnamomi 3 parts.
Embodiment 2:
: a kind of Chinese medicine preparation for the treatment of coronary heart disease, according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 35 parts, Radix Salviae Miltiorrhizae 35 parts, Radix Rehmanniae Preparata 20 parts, Rhizoma Chuanxiong 20 parts, Rhizoma Polygonati 8 parts, 35 parts, Poria, Herb Gynostemmae Pentaphylli 8 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 20 parts, Radix Polygalae 5 parts, the Cortex Eucommiae 10 parts, Fructus Crataegi 2 parts, Semen Plantaginis 5 parts, Ramulus Cinnamomi 35 parts, Herba Equiseti Hiemalis 20 parts, the Rhizoma Anemarrhenae 10 parts and Cortex Cinnamomi 5 parts.
Embodiment 3:
Formula described in embodiment 1 prepares the Chinese medicine preparation for the treatment of coronary heart disease in accordance with the following methods: take raw material of Chinese medicine according to formula and join in container, add water and cover powder and soak 10 minutes, add water again and do not have powder 3 centimetres, decoct with high heat and use slow fire boiling again instead 20 minutes to boiling, get filtrate; And then add water and do not have powder 3 centimetres, decoct with high heat and uses slow fire boiling again instead 15 minutes to boiling, then remove slag and get filtrate, twice filtrate merges.
Embodiment 4:
Formula described in embodiment 2 prepares the Chinese medicine preparation for the treatment of coronary heart disease in accordance with the following methods: take raw material of Chinese medicine according to formula and join in container, add water and cover powder and soak 20 minutes, add water again and do not have powder 5 centimetres, decoct with high heat and use slow fire boiling again instead 30 minutes to boiling, get filtrate; And then add water and do not have powder 5 centimetres, decoct with high heat and uses slow fire boiling again instead 20 minutes to boiling, then remove slag and get filtrate, twice filtrate merges.
Claims (4)
1. treat the Chinese medicine preparation of coronary heart disease for one kind, it is characterized in that according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 25 ~ 35 parts, Radix Salviae Miltiorrhizae 25 ~ 35 parts, Radix Rehmanniae Preparata 10 ~ 20 parts, Rhizoma Chuanxiong 10 ~ 20 parts, Rhizoma Polygonati 5 ~ 8 parts, 25 ~ 35 parts, Poria, Herb Gynostemmae Pentaphylli 5 ~ 8 parts, 5 ~ 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 10 ~ 20 parts, Radix Polygalae 3 ~ 5 parts, the Cortex Eucommiae 5 ~ 10 parts, Fructus Crataegi 1 ~ 2 part, Semen Plantaginis 3 ~ 5 parts, Ramulus Cinnamomi 25 ~ 35 parts, Herba Equiseti Hiemalis 10 ~ 20 parts, the Rhizoma Anemarrhenae 5 ~ 10 parts and Cortex Cinnamomi 3 ~ 5 parts.
2. a kind of Chinese medicine preparation for the treatment of coronary heart disease according to claim 1, it is characterized in that according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 25 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Rehmanniae Preparata 10 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Polygonati 5 parts, 25 parts, Poria, Herb Gynostemmae Pentaphylli 5 parts, 5 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 10 parts, Radix Polygalae 3 parts, the Cortex Eucommiae 5 parts, Fructus Crataegi 1 part, Semen Plantaginis 3 parts, Ramulus Cinnamomi 25 parts, Herba Equiseti Hiemalis 10 parts, the Rhizoma Anemarrhenae 5 parts and Cortex Cinnamomi 3 parts.
3. a kind of Chinese medicine preparation for the treatment of coronary heart disease according to claim 1, it is characterized in that according to weight parts, formulated by following raw material of Chinese medicine: Radix Notoginseng 35 parts, Radix Salviae Miltiorrhizae 35 parts, Radix Rehmanniae Preparata 20 parts, Rhizoma Chuanxiong 20 parts, Rhizoma Polygonati 8 parts, 35 parts, Poria, Herb Gynostemmae Pentaphylli 8 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Coptidis 20 parts, Radix Polygalae 5 parts, the Cortex Eucommiae 10 parts, Fructus Crataegi 2 parts, Semen Plantaginis 5 parts, Ramulus Cinnamomi 35 parts, Herba Equiseti Hiemalis 20 parts, the Rhizoma Anemarrhenae 10 parts and Cortex Cinnamomi 5 parts.
4. the preparation method of the Chinese medicine preparation of a treatment coronary heart disease according to claim 1, it is characterized in that preparing in accordance with the following methods: take raw material of Chinese medicine according to formula and join in container, add water and cover powder immersion 10 ~ 20 minutes, add water again and do not have powder 3 ~ 5 centimetres, decoct with high heat and use slow fire boiling again instead 20 ~ 30 minutes to boiling, get filtrate; And then add water and do not have powder 3 ~ 5 centimetres, decoct with high heat and uses slow fire boiling again instead 15 ~ 20 minutes to boiling, then remove slag and get filtrate, twice filtrate merges.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410757725.5A CN104491406A (en) | 2014-12-10 | 2014-12-10 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410757725.5A CN104491406A (en) | 2014-12-10 | 2014-12-10 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491406A true CN104491406A (en) | 2015-04-08 |
Family
ID=52932920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410757725.5A Pending CN104491406A (en) | 2014-12-10 | 2014-12-10 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491406A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113117017A (en) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
-
2014
- 2014-12-10 CN CN201410757725.5A patent/CN104491406A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113117017A (en) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105687824A (en) | Traditional Chinese medicine granules for treating postpartum night sweat and preparation method | |
| CN103432390B (en) | Medicament for treating coronary heart disease and preparation method thereof | |
| CN102366468A (en) | Traditional Chinese medicine for treating vitiligo | |
| CN103007062B (en) | Chinese medicinal preparation for treating cerebral thrombosis | |
| CN103211930A (en) | Traditional Chinese preparation for reducing blood fat and blood pressure | |
| CN101095923B (en) | Chinese traditional medicine for treating ectopic pregnancy | |
| CN104740268A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
| CN104147536A (en) | Medicine composition for treating haemorrhoids and preparation method thereof | |
| CN102293964B (en) | Medicine for treating gastric ulcer, and preparation method thereof | |
| CN104958626A (en) | Medicine for treating colitis and preparation method thereof | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN104825795A (en) | Traditional Chinese medicinal capsule for treating arrhythmia | |
| CN104043058A (en) | Traditional Chinese medicinal preparation for treating kidney deficiency type lumbar disc herniation and preparation method thereof | |
| CN104491406A (en) | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation | |
| CN105726932A (en) | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof | |
| CN104840874A (en) | Traditional Chinese medicine pills used for aneurysm postoperative rehabilitation treatment and preparation method thereof | |
| CN106310137A (en) | Traditional Chinese medicine composition for treating qi stagnation and blood stasis syndrome due to coronary disease and angina and preparation method thereof | |
| CN105726853A (en) | Traditional Chinese medicine preparation for treating angina pectoris and preparation method thereof | |
| CN105168549A (en) | Health product composition for relieving insomnia or assisting in treatment of insomnia and preparation method thereof | |
| CN105412864A (en) | Pain relieving ointment for treating prolapse of lumbar intervertebral disc | |
| CN105148122A (en) | Traditional Chinese medicine pills for treating pelvic abscess and preparation method | |
| CN104189714A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN105726813A (en) | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof | |
| CN105079586A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN101979043B (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
| RJ01 | Rejection of invention patent application after publication |